Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Lane3 who wrote (10210)	10/6/2009 12:17:18 PM
From: i-node	Respond to of 42652

>> Ouch! VAT is the tax they can "hide" from the people. They can do it and Obama can still, ridiculously, claim he didn't violate his "Read My Lips" pledge. It is an economy killer, though.

To: Lane3 who wrote (10210)	10/6/2009 12:46:27 PM
From: John Koligman	Read Replies (2) \| Respond to of 42652

Here is some text on what she said.... Pelosi says new tax is 'on the table' By Michael O'Brien - 10/06/09 10:59 AM ET A new value-added tax (VAT) is "on the table" to help the U.S. address its fiscal liabilities, House Speaker Nancy Pelosi (D-Calif.) said Monday night. Pelosi, appearing on PBS's "The Charlie Rose Show" asserted that "it's fair to look at" the VAT as part of an overhaul of the nation's tax code. "I would say, Put everything on the table and subject it to the scrutiny that it deserves," Pelosi told Rose when asked if the VAT has any appeal to her. The VAT is a tax on manufacturers at each stage of production on the amount of value an additional producer adds to a product. Pelosi argued that the VAT would level the playing field between U.S. and foreign manufacturers, the latter of which do not have pension and healthcare costs included in the price of their goods because their governments provide those services, financed by similar taxes. "They get a tax off of that and they use that money to pay the healthcare for their own workers," Pelosi said, using the example of auto manufacturers. "So their cars coming into our country don't have a healthcare component cost. "Somewhere along the way, a value-added tax plays into this. Of course, we want to take down the healthcare cost, that's one part of it," the Speaker added. "But in the scheme of things, I think it's fair look at a value- added tax as well." Pelosi said that any new taxes would come after the Congress finishes the healthcare debate consuming most lawmakers' time, and that it may come as part of a larger overhaul to the tax code. The Speaker also emphasized that any reworking of the tax code would not result in an increase in taxes on middle-class Americans

To: Lane3 who wrote (10210)	10/6/2009 3:27:08 PM
From: Peter Dierks	Read Replies (1) \| Respond to of 42652

A Nobel for American Medicine We need to shield scientific innovation from the budget ravages of government control. OCTOBER 6, 2009. Hats off to Elizabeth Blackburn, Carol Greider and Jack Szostak, the three American scientists awarded the 2009 Nobel Prize in medicine yesterday. Their cell research demonstrates that we're on the cusp of an era of medical innovation that could radically improve lives and life spans, if government lets it blossom. The trio was honored for discovering how chromosomes act to protect themselves from degrading when cells divide by using an enzyme called telomerase. Subsequent studies have found that telomerase is closely tied to aging and human cancers, and work on the enzyme has become a popular area of drug research. Their discoveries "have added a new dimension to our understanding of the cell, shed light on disease mechanisms, and stimulated the development of potential new therapies," said the prize committee. It's worth noting that the British-born Szostak and the Australian-born Blackburn are immigrants who chose to work at U.S. research institutions, which continue to be the world's best. Low-skill foreigners tend to dominate the immigration debate, but if the U.S. is to remain a leader in scientific innovation, we'll need to keep our borders open to the world's top talent. We'll also need to protect those institutions from the budget ravages (see above) of government-controlled medicine. online.wsj.com